NCT02433548

Brief Summary

Femoral neck fracture is very common in the elderly and can produce severe to moderate pain. As this pathology is not life-threatening, waiting time in the emergency department may be prolonged due to the high number of unforeseen cases with patients remaining in pain. Fascia iliaca block consists of injecting local anaesthetics below the fascia iliaca, resulting in the anaesthesia of the femoral, the lateral cutaneous and the obturator nerves, with effective analgesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

October 20, 2014

Completed
7 months until next milestone

First Posted

Study publicly available on registry

May 5, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

September 27, 2016

Status Verified

September 1, 2016

Enrollment Period

1.8 years

First QC Date

October 20, 2014

Last Update Submit

September 26, 2016

Conditions

Keywords

AnalgesiaEmergency medicineAnesthesia, Regional

Outcome Measures

Primary Outcomes (1)

  • Pain scores at rest

    45 minutes after the injection

Secondary Outcomes (4)

  • Pain scores at rest

    60 min, 4h, 8h, 12h, 24h after the injection

  • Pain scores on movement

    60 min, 4h, 8h, 12h, 24h after the injection

  • Morphine consumption

    60 min, 4h, 8h, 12h, 24h after the injection

  • Length of stay

    up to 3 weeks

Study Arms (2)

Fascia iliaca block

EXPERIMENTAL

Fascia iliaca block (Injection of 30 mLs of bupivacaine 0.5% with epinephrine 5 mcg/mL below the fascia iliaca, Carbostesin®)

Procedure: Fascia iliaca block

Sham injection

SHAM COMPARATOR

No fascia iliaca block (Sham injection = Subcutaneous injection of 5 cc of normal saline, no intervention)

Procedure: Sham injection

Interventions

injection of 30 mLs below the fascia iliaca

Fascia iliaca block

subcutaneous of 5 cc of normal saline

Sham injection

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- patients with femoral neck fracture in the emergency department

You may not qualify if:

  • presence of demencia
  • body weight less than 40kg
  • presence of a cancer or patients receiving chemotherapy
  • allergy to local anaesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHUVaudois

Lausanne, Canton of Vaud, 1011, Switzerland

Location

Related Publications (2)

  • Guay J, Kopp S. Peripheral nerve blocks for hip fractures in adults. Cochrane Database Syst Rev. 2020 Nov 25;11(11):CD001159. doi: 10.1002/14651858.CD001159.pub3.

  • Pasquier M, Taffe P, Hugli O, Borens O, Kirkham KR, Albrecht E. Fascia iliaca block in the emergency department for hip fracture: a randomized, controlled, double-blind trial. BMC Geriatr. 2019 Jul 1;19(1):180. doi: 10.1186/s12877-019-1193-0.

MeSH Terms

Conditions

Femoral Neck FracturesAgnosia

Interventions

salicylhydroxamic acid

Condition Hierarchy (Ancestors)

Hip FracturesFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Eric Albrecht, MD

    Centre Hospitalier Universitaire Vaudois

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PD Dr Eric Albrecht, MD, MER, DESA, Program Director, Regional Anaesthesia

Study Record Dates

First Submitted

October 20, 2014

First Posted

May 5, 2015

Study Start

October 1, 2014

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

September 27, 2016

Record last verified: 2016-09

Locations